Close Menu

NEW YORK – Fulgent Genetics reported after the close of the market on Tuesday that its fourth quarter revenues grew 48 percent year over year.

For the three months ended Dec. 31, 2019 the company reported revenues of $8.4 million, up from $5.7 million in Q4 2018. The firm said that it delivered 13,977 billable tests during Q4, more than double the number of tests in the prior-year period.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.